Skip to main content
construction release_alert
Scholars@Duke will be undergoing maintenance April 11-15. Some features may be unavailable during this time.
cancel

Testing the efficacy of AR degrading compounds in enzalutamide-resistant prostate cancer

Research Grant
Duke Scholars

Administered By

Medicine, Medical Oncology

Awarded By

Arvinas Inc.

Start Date

January 5, 2017

End Date

January 8, 2019
 

Administered By

Medicine, Medical Oncology

Awarded By

Arvinas Inc.

Start Date

January 5, 2017

End Date

January 8, 2019